Variable and fixed costs in NHS radiotherapy; consequences for increasing hypo fractionation
Affiliation
Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Level 10, Worsley building, Clarendon Way, Leeds, LS2 9LU; Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust.Issue Date
2021
Metadata
Show full item recordCitation
Spencer K, Defourny N, Tunstall D, Cosgrove V, Kirkby K, Henry A, et al. Variable and fixed costs in NHS radiotherapy; consequences for increasing hypo fractionation Vol. 166, Radiotherapy and Oncology. Elsevier BV; 2022. p. 180–8.Journal
Radiotherapy and OncologyDOI
10.1016/j.radonc.2021.11.035PubMed ID
34890735Type
Articleae974a485f413a2113503eed53cd6c53
10.1016/j.radonc.2021.11.035
Scopus Count
Collections
Related articles
- Cost and Cost-Effectiveness of Image Guided Partial Breast Irradiation in Comparison to Hypofractionated Whole Breast Irradiation.
- Authors: Shah C, Ward MC, Tendulkar RD, Cherian S, Vicini F, Singer ME
- Issue date: 2019 Feb 1
- Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
- Authors: Lunsford LD, Flickinger JC, Larson D
- Issue date: 1997
- Introduction of ultra-hypofractionation in breast cancer: Implications for costs and resource use.
- Authors: Busschaert SL, Kimpe E, Barbé K, De Ridder M, Putman K
- Issue date: 2024 Jan
- Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
- Authors: Widmark A, Gunnlaugsson A, Beckman L, Thellenberg-Karlsson C, Hoyer M, Lagerlund M, Kindblom J, Ginman C, Johansson B, Björnlinger K, Seke M, Agrup M, Fransson P, Tavelin B, Norman D, Zackrisson B, Anderson H, Kjellén E, Franzén L, Nilsson P
- Issue date: 2019 Aug 3
- Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.
- Authors: Fransson P, Nilsson P, Gunnlaugsson A, Beckman L, Tavelin B, Norman D, Thellenberg-Karlsson C, Hoyer M, Lagerlund M, Kindblom J, Ginman C, Johansson B, Björnlinger K, Seke M, Agrup M, Zackrisson B, Kjellén E, Franzén L, Widmark A
- Issue date: 2021 Feb